The hypothesis that engagement of PD-1:PD-L1 pathway might dampen immune responses for tumors was confirmed by the observation that overexpression of PD-L1 on a mouse mastocytoma cell line inhibits CD8+ T cell cytolytic activity through PD-1 ligation, which intensifies tumor growth and invasiveness (142). The gene discussed is PDCD1; the disease is neoplasm.